Medical eligibility, contraceptive choice, and intrauterine device acceptance among HIV-infected women receiving antiretroviral therapy in Lilongwe, Malawi

International Journal of Gynecology and Obstetrics

Volumn 126, Issue 3, 2014, Pages 213-216

  Haddad, Lisa B ^a   Feldacker, Caryl ^b,c   Jamieson, Denise J ^a   Tweya, Hannock ^b   Cwiak, Carrie ^a   Bryant, Amy G ^d   Hosseinipour, Mina C ^d,e   Chaweza, Thomas ^b   Mlundira, Linly ^b   Kachale, Fanny ^f   Stuart, Gretchen S ^d   Hoffman, Irving ^d   Phiri, Sam ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LIGHTHOUSE TRUST   (Malawi)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

^e UNIVERSITY OF NORTH CAROLINA PROJECT   (Malawi)

^f MINISTRY OF HEALTH   (Malawi)

Author keywords

Antiretroviral therapy; Contraception; HIV; Intrauterine contraception; Intrauterine device; Malawi; Medical eligibility

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CONTRACEPTIVE AGENT; COPPER INTRAUTERINE DEVICE; GESTAGEN; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; RITONAVIR;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CONTRACEPTION; CONTRACEPTIVE IMPLANT; FAMILY PLANNING; FEMALE; FEMALE CONTRACEPTIVE DEVICE; HEALTH CARE ACCESS; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MALAWI; PATIENT ATTITUDE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT PREFERENCE; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; STRUCTURED INTERVIEW; ADOLESCENT; CONTRACEPTIVE BEHAVIOR; COPPER INTRAUTERINE DEVICE; DECISION MAKING; HIV INFECTIONS; ORGANIZATION AND MANAGEMENT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHOICE BEHAVIOR; CONTRACEPTION BEHAVIOR; ELIGIBILITY DETERMINATION; FEMALE; HIV INFECTIONS; HUMANS; INTRAUTERINE DEVICES, COPPER; MALAWI; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 84905574424     PISSN: 00207292     EISSN: 18793479     Source Type: Journal    
DOI: 10.1016/j.ijgo.2014.03.026     Document Type: Article

References (25)

1. UNAIDS, and UNFPA Making condoms work for HIV prevention http://data.unaids.org/publications/irc-pub06/jc941-cuttingedge-en.pdf Published 2004. Accessed March 17, 2014
2. World Health Organization (WHO) Department of Reproductive Health and Research, and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP) Knowledge for health project Family planning: a global handbook for providers (2011 update) 2011 CCP and WHO Baltimore, MD; Geneva, Switzerland
3. K.M. Wall, B. Vwalika, L. Haddad, N.H. Khu, C. Vwalika, and W. Kilembe et al. Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia J Acquir Immune Defic Syndr 63 1 2013 86 95
4. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. Fourth Edition. http://whqlibdoc.who.int/publications/2010/9789241563888- eng.pdf. Published 2010. Accessed March 17, 2014.
5. S.K. Sinei, C.S. Morrison, C. Sekadde-Kigondu, M. Allen, and D. Kokonya Complications of use of intrauterine devices among HIV-1-infected women Lancet 351 9111 1998 1238 1241
6. C.S. Morrison, C. Sekadde-Kigondu, S.K. Sinei, D.H. Weiner, C. Kwok, and D. Kokonya Is the intrauterine device appropriate contraception for HIV-1-infected women? BJOG 108 8 2001 784 790
7. B.A. Richardson, C.S. Morrison, C. Sekadde-Kigondu, S.K. Sinei, J. Overbaugh, and D.D. Panteleeff et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA AIDS 13 15 1999 2091 2097
8. S.B. Mostad, S. Jackson, J. Overbaugh, M. Reilly, B. Chohan, and K. Mandaliya et al. Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle J Infect Dis 178 4 1998 983 991
9. D. Hubacher, I. Mavranezouli, and E. McGinn Unintended pregnancy in sub-Saharan Africa: magnitude of the problem and potential role of contraceptive implants to alleviate it Contraception 78 1 2008 73 78
10. National Statistical Office, and ICF Macro Malawi Demographic and Health Survey 2010 http://dhsprogram.com/pubs/pdf/FR247/FR247.pdf Published September 2011. Accessed March 17, 2014
11. E. Zuehlke Reducing Unintended Pregnancy and Unsafely Performed Abortion Through Contraceptive Use http://www.prb.org/Publications/Articles/2009/ unintendedpregnancyandabortion.aspx Published September 2009. Accessed March 17, 2014
12. J.R. Chinkonde-Nkhoma, M. Hosseinipour, I. Mofolo, A. Moses, T. Mtande, and E. Kamanga et al. A review of the 'Option B Plus' roll-out in the five districts of Malawi Abstract presented at: AIDS 2012: 19th International AIDS Society Conference 2012 Washington, DC
13. B. Tippett Barr, E. Mhango, L. Tenthani, G. Zomba, S. Makombe, and M. Eliya et al. Uptake and Retention in Malawi's Option B + PMTCT Program: Lifelong ART for all HIV + Paper presenteed at: Pregnant or Lactating Women. 20th Conference on Retroviruses and Opportunistic Infections (CROI) 2013 Atlanta, GA
14. L. Haddad, C. Cwiak, D. Jamieson, C. Feldacker, H. Tweya, and M. Hosseinipour et al. Contraceptive adherence and acceptability among HIV-infected women in Malawi: A Randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate Contraception 88 6 2013 737 743
15. M.K. Whiteman, D.M. Kissin, A. Samarina, K.M. Curtis, N. Akatova, and P.A. Marchbanks et al. Determinants of contraceptive choice among women with HIV AIDS 23 Suppl. 1 2009 S47 S54
16. National Statistical Office (NSO), and ICF Macro Malawi Demographic and Health Survey 2010 2011 NSO and ICF Macro Zomba, Malawi, and Calverton, Maryland, USA
17. R. Heffron, D. Donnell, H. Rees, C. Celum, N. Mugo, and E. Were et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study Lancet Infect Dis 12 1 2012 19 26
18. E.M. Stringer, J. Levy, M. Sinkala, B.H. Chi, I. Matongo, and N. Chintu et al. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial AIDS 23 11 2009 1377 1382
19. C.S. Morrison, S. Skoler-Karpoff, C. Kwok, P.L. Chen, J. van de Wijgert, and M. Gehret-Plagianos et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa AIDS 26 4 2012 497 504
20. J. Baeten, L. Lavreys, and J. Overbaugh The influence of hormonal contraceptive use on HIV-1 transmission and disease progression Clin Infect Dis 45 3 2007 360 369
21. C.A. Blish, and J.M. Baeten Hormonal contraception and HIV-1 transmission Am J Reprod Immunol 65 3 2011 302 307
22. World Health Organization Hormonal contraception and HIV. Technical Statement http://whqlibdoc.who.int/hq/2012/WHO-RHR-12.08-eng.pdf Published February 16, 2012. Accessed March 17, 2014
23. M.I. Rodriguez, M.F. Reeves, and A.B. Caughey Evaluating the competing risks of HIV acquisition and maternal mortality in Africa: a decision analysis BJOG 119 9 2012 1067 1073
24. J.A. Robinson, R. Jamshidi, and A.E. Burke Contraception for the HIV-positive woman: a review of interactions between hormonal contraception and antiretroviral therapy Infect Dis Obstet Gynecol 2012 2012 890160
25. N. Leticee, J.P. Viard, A. Yamgnane, M. Karmochkine, and A. Benachi Contraceptive failure of etonogestrel implant in patients treated with antiretrovirals including efavirenz Contraception 85 4 2012 425 427